Compare ARQT & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | PATK |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2020 | 1994 |
| Metric | ARQT | PATK |
|---|---|---|
| Price | $26.54 | $83.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $34.00 | ★ $122.75 |
| AVG Volume (30 Days) | ★ 1.5M | 483.7K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | 0.03 | ★ 2.37 |
| Revenue | ★ $376,072,000.00 | $29,000,000.00 |
| Revenue This Year | $34.85 | $5.78 |
| Revenue Next Year | $29.39 | $6.51 |
| P/E Ratio | $853.67 | ★ $35.77 |
| Revenue Growth | 91.34 | ★ 262.50 |
| 52 Week Low | $15.10 | $81.29 |
| 52 Week High | $31.77 | $148.50 |
| Indicator | ARQT | PATK |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 45.58 |
| Support Level | $24.91 | $82.35 |
| Resistance Level | $28.35 | $89.83 |
| Average True Range (ATR) | 1.30 | 3.29 |
| MACD | -0.15 | -0.05 |
| Stochastic Oscillator | 40.18 | 35.86 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.